PEAK PROCESSING LIMITED — Share Issue/Capital Change 2020

Dec 20, 2020

==> picture [596 x 149] intentionally omitted <==

ASX Announcement | 21 December 2020 Althea Group Holdings (ASX:AGH)

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (“Act”)

ALTHEA GROUP HOLDINGS LIMITED (ASX Code: AGH) ( "Company" ) issued 13,636,364 fully paid ordinary shares pursuant to the institutional placement announced by the Company on 15 December 2020.

The Company advises that:

• the shares were issued without disclosure to investors under Part 6D.2 of the Act;

• this notice is being given under section 708A(5)(e) of the Act;

• as at the date of this notice, the Company has complied with:

  • the provisions of Chapter 2M of the Act as they apply to it; and

  • section 674 of the Act; and

• as at the date of this notice, there is no excluded information of the type referred to in subsections 708A(7) and 708A(8) of the Act that is required to be set out in this notice.

-ENDS-

Authorised by: Robert Meissner, Company Secretary

For further information, please contact:

Althea Media Enquiries Investor Relations Josh Fegan Dan Francome Jane Morgan CEO & Managing Director Media Relations Investor Relations Partner M: 1300 70 20 20 P: +613 9650 5096 M: +61 405 555 618 E: contact@althea.life E: dfrancome@althea.life E: jm@janemorganmanagement.com.au

Althea Group Holdings Limited (ASX:AGH)

Althea Group Holdings Ltd (ASX:AGH) is a global pharmaceutical company and supplier of medicinal cannabis. Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.

Althea currently operates within highly regulated medicinal cannabis markets including Australia, United Kingdom and Germany, with plans to expand the brand into emerging markets across the world.

To learn more, please visit: www.althea.life

==> picture [596 x 91] intentionally omitted <==